Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Net Cash Flow (2023 - 2026)

Rallybio's Net Cash Flow history spans 3 years, with the latest figure at -$748000.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 93.45% to -$748000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $17.5 million, a 264.96% increase, with the full-year FY2025 number at $17.5 million, up 264.96% from a year prior.
  • Net Cash Flow hit -$748000.0 in Q4 2025 for Rallybio, down from $22.7 million in the prior quarter.
  • Over the last five years, Net Cash Flow for RLYB hit a ceiling of $22.7 million in Q3 2025 and a floor of -$17.4 million in Q1 2023.
  • Historically, Net Cash Flow has averaged -$2.1 million across 3 years, with a median of -$3.9 million in 2024.
  • The widest YoY moves for Net Cash Flow: up 164.54% in 2024, down 313.96% in 2024.
  • Tracing RLYB's Net Cash Flow over 3 years: stood at $5.3 million in 2023, then plummeted by 313.96% to -$11.4 million in 2024, then soared by 93.45% to -$748000.0 in 2025.
  • Business Quant data shows Net Cash Flow for RLYB at -$748000.0 in Q4 2025, $22.7 million in Q3 2025, and -$5.3 million in Q2 2025.